Srinivasa P. S. Rao
ORCID: 0000-0002-7156-5725Also affiliated with Novant Health, Novartis (United States), Health Biomed (China), NovaBay Pharmaceuticals (United States), Novartis (Ireland)
Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.
Indexed papers
Why this DataRank?
An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.
Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.
Read the full methodology →Papers
Driven by 5 papers. Top paper: “An end is in sight: a perspective on PCR as an endpoint for Chagas disease treatment trials”.
Srinivasa P. S. Rao, Gerhild Angyalosi, Xiaojun Zhao, Leticia Carballo, Caroline Demacq +6 more
Daisy Chen, John Wallis, Miles G. Siegel, Anna Adam, Selina Bopp +44 more
Constanza Rodríguez, Cintia L. Araujo Furlan, Carolina Abrate, Laura Almada, Camila M. S. Giménez +7 more
Daisy Chen, John Wallis, Miles G. Siegel, Anna Adam, Selina Bopp +44 more
Constanza Rodríguez, Camila M. S. Giménez, Cintia L. Araujo Furlan, Carolina Abrate, Laura Almada +8 more